VANGUARD GROUP INC - CONTEXT THERAPEUTICS INC ownership

CONTEXT THERAPEUTICS INC's ticker is and the CUSIP is 21077P108. A total of 17 filers reported holding CONTEXT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CONTEXT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$896,171
-2.5%
593,491
+3.3%
0.00%
Q2 2023$919,520
+185.2%
574,700
+0.2%
0.00%
Q1 2023$322,365
-22.8%
573,400
-10.5%
0.00%
Q4 2022$417,650
-41.3%
640,863
+0.0%
0.00%
Q3 2022$711,000
-46.7%
640,699
+1.9%
0.00%
Q2 2022$1,333,000
+159.8%
628,979
+166.2%
0.00%
Q1 2022$513,000
-10.2%
236,279
+10.1%
0.00%
Q4 2021$571,000214,6790.00%
Other shareholders
CONTEXT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 883,654$1,873,0000.79%
Worth Venture Partners, LLC 297,612$565,0000.33%
AIGH Capital Management LLC 1,191,771$1,188,0000.31%
Knoll Capital Management, LLC 139,520$296,0000.17%
swisspartners Ltd. 42,235$92,0000.09%
DIFESA CAPITAL MANAGEMENT, LP 34,878$74,0000.04%
Virtu Financial LLC 46,445$98,0000.01%
Veritable, L.P. 110,249$234,0000.00%
HighTower Advisors, LLC 125,852$267,0000.00%
Atria Wealth Solutions, Inc. 24,000$51,0000.00%
View complete list of CONTEXT THERAPEUTICS INC shareholders